These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 28178265)
1. Computational investigation of sphingosine kinase 1 (SphK1) and calcium dependent ERK1/2 activation downstream of VEGFR2 in endothelial cells. Bazzazi H; Popel AS PLoS Comput Biol; 2017 Feb; 13(2):e1005332. PubMed ID: 28178265 [TBL] [Abstract][Full Text] [Related]
2. Combining Multikinase Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor and Cluster of Differentiation 47 Signaling Pathways Is Predicted to Increase the Efficacy of Antiangiogenic Combination Therapies. Zhang Y; Popel AS; Bazzazi H ACS Pharmacol Transl Sci; 2023 May; 6(5):710-726. PubMed ID: 37200806 [TBL] [Abstract][Full Text] [Related]
3. Geniposide alleviates VEGF-induced angiogenesis by inhibiting VEGFR2/PKC/ERK1/2-mediated SphK1 translocation. Wang Y; Wu H; Gui BJ; Liu J; Rong GX; Deng R; Bu YH; Zhang H Phytomedicine; 2022 Jun; 100():154068. PubMed ID: 35358930 [TBL] [Abstract][Full Text] [Related]
4. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway. Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437 [TBL] [Abstract][Full Text] [Related]
5. c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1. Anselmi F; Orlandini M; Rocchigiani M; De Clemente C; Salameh A; Lentucci C; Oliviero S; Galvagni F Angiogenesis; 2012 Jun; 15(2):187-97. PubMed ID: 22327338 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of VEGFR2 Activation and Its Downstream Signaling to ERK1/2 and Calcium by Thrombospondin-1 (TSP1): Bazzazi H; Isenberg JS; Popel AS Front Physiol; 2017; 8():48. PubMed ID: 28220078 [TBL] [Abstract][Full Text] [Related]
7. Regulation of VEGFR2 trafficking and signaling by Rab GTPase-activating proteins. Xie Y; Mansouri M; Rizk A; Berger P Sci Rep; 2019 Sep; 9(1):13342. PubMed ID: 31527750 [TBL] [Abstract][Full Text] [Related]
8. Computational model of VEGFR2 pathway to ERK activation and modulation through receptor trafficking. Tan WH; Popel AS; Mac Gabhann F Cell Signal; 2013 Dec; 25(12):2496-510. PubMed ID: 23993967 [TBL] [Abstract][Full Text] [Related]
9. Molecular controls of lymphatic VEGFR3 signaling. Deng Y; Zhang X; Simons M Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775 [TBL] [Abstract][Full Text] [Related]
10. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels. Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432 [TBL] [Abstract][Full Text] [Related]
11. Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis. Lin YC; Chao TY; Yeh CT; Roffler SR; Kannagi R; Yang RB Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):144-155. PubMed ID: 27834687 [TBL] [Abstract][Full Text] [Related]
13. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features. Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971 [TBL] [Abstract][Full Text] [Related]
14. Mechanistic insight into activation of MAPK signaling by pro-angiogenic factors. Song M; Finley SD BMC Syst Biol; 2018 Dec; 12(1):145. PubMed ID: 30591051 [TBL] [Abstract][Full Text] [Related]
15. ApoA-I induces S1P release from endothelial cells through ABCA1 and SR-BI in a positive feedback manner. Liu X; Ren K; Suo R; Xiong SL; Zhang QH; Mo ZC; Tang ZL; Jiang Y; Peng XS; Yi GH J Physiol Biochem; 2016 Dec; 72(4):657-667. PubMed ID: 27377933 [TBL] [Abstract][Full Text] [Related]
16. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway. Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659 [TBL] [Abstract][Full Text] [Related]
17. VEGFR2 is activated by high-density lipoproteins and plays a key role in the proangiogenic action of HDL in ischemia. Cannizzo CM; Adonopulos AA; Solly EL; Ridiandries A; Vanags LZ; Mulangala J; Yuen SCG; Tsatralis T; Henriquez R; Robertson S; Nicholls SJ; Di Bartolo BA; Ng MKC; Lam YT; Bursill CA; Tan JTM FASEB J; 2018 Jun; 32(6):2911-2922. PubMed ID: 29401597 [TBL] [Abstract][Full Text] [Related]
18. The VEGFR2 and PKA pathways converge at MEK/ERK1/2 to promote survival in serum deprived neuronal cells. Gomes E; Papa L; Hao T; Rockwell P Mol Cell Biochem; 2007 Nov; 305(1-2):179-90. PubMed ID: 17646929 [TBL] [Abstract][Full Text] [Related]
19. Dynasore impairs VEGFR2 signalling in an endocytosis-independent manner. Basagiannis D; Zografou S; Galanopoulou K; Christoforidis S Sci Rep; 2017 Mar; 7():45035. PubMed ID: 28327657 [TBL] [Abstract][Full Text] [Related]